Trevi Therapeutics (TRVI) Stock Chart & Stock Price History $2.94 -0.12 (-3.92%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Trevi Therapeutics Stock Price Performance5 Day Performance-5.61%1 Month Performance-11.83%3 Month Performance-7.39%6 Month Performance+0.51%Year-To-Date Performance+119.78%1 Year Performance+65.45% Receive TRVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> TRVI Stock Chart for Thursday, October, 31, 2024 TRVI Chart by TradingView Trevi Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/31/2024$3.06$2.95-3.76%$3.05$2.94231,497 shs$213.78 million10/30/2024$3.08$3.06-0.65%$3.15$2.99291,410 shs$222.13 million10/29/2024$3.18$3.08-3.14%$3.17$3.04287,389 shs$223.58 million10/28/2024$3.12$3.18+1.92%$3.29$3.15419,857 shs$230.84 million10/25/2024$3.11$3.12+0.32%$3.15$2.97712,965 shs$219.05 million10/24/2024$3.21$3.11-3.12%$3.23$3.09213,823 shs$225.76 million Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/23/2024$3.23$3.21-0.62%$3.26$3.13309,722 shs$226.10 million10/22/2024$3.35$3.23-3.58%$3.40$3.082.61 million shs$227.51 million10/21/2024$3.12$3.35+7.37%$3.44$3.161.59 million shs$243.18 million10/18/2024$3.12$3.12$3.14$3.04290,212 shs$219.76 million10/17/2024$3.20$3.12-2.50%$3.33$3.10317,816 shs$226.48 million10/16/2024$3.18$3.20+0.63%$3.29$3.11460,007 shs$225.39 million10/15/2024$3.18$3.18$3.31$3.08153,456 shs$223.98 million10/14/2024$3.12$3.18+1.92%$3.22$3.09310,310 shs$223.98 million10/11/2024$3.00$3.12+4.00%$3.18$2.99208,497 shs$226.48 million10/10/2024$2.99$3.00+0.33%$3.12$2.88304,142 shs$211.31 million10/09/2024$3.15$2.99-5.08%$3.16$2.99139,966 shs$217.04 million10/08/2024$2.88$3.15+9.38%$3.18$2.83436,338 shs$221.87 million10/07/2024$3.02$2.88-4.64%$3.01$2.86123,885 shs$202.85 million10/04/2024$3.02$3.02$3.07$2.77382,277 shs$212.71 million10/03/2024$3.19$3.02-5.33%$3.19$2.97188,485 shs$212.71 million10/02/2024$3.11$3.19+2.57%$3.28$3.01282,015 shs$224.69 million10/01/2024$3.34$3.11-6.89%$3.36$3.08393,137 shs$225.76 million09/30/2024$3.33$3.34+0.30%$3.37$3.00246,724 shs$235.25 million09/27/2024$3.15$3.33+5.71%$3.50$3.11419,467 shs$241.73 million09/26/2024$3.08$3.15+2.27%$3.16$2.941.82 million shs$228.66 million09/25/2024$3.17$3.08-2.84%$3.26$3.05394,867 shs$223.58 million09/24/2024$3.30$3.17-3.94%$3.31$3.03402,313 shs$223.28 million09/23/2024$3.44$3.30-4.07%$3.47$3.25206,592 shs$232.44 million09/20/2024$3.50$3.44-1.71%$3.57$3.401.12 million shs$242.30 million09/19/2024$3.41$3.50+2.64%$3.55$3.43482,203 shs$246.52 million09/18/2024$3.33$3.41+2.40%$3.59$3.34315,382 shs$247.53 million09/17/2024$3.51$3.33-5.13%$3.69$3.20435,897 shs$241.73 million09/16/2024$3.37$3.51+4.15%$3.68$3.38720,365 shs$254.79 million09/13/2024$3.30$3.37+2.12%$3.62$3.31441,799 shs$244.63 million09/12/2024$3.30$3.30$3.40$3.29111,963 shs$239.55 million09/11/2024$3.15$3.30+4.76%$3.40$3.09410,114 shs$239.55 million09/10/2024$3.12$3.15+0.96%$3.24$3.01235,533 shs$221.87 million09/09/2024$2.95$3.12+5.76%$3.18$2.99480,262 shs$219.76 million09/06/2024$3.10$2.95-4.84%$3.10$2.9371,463 shs$207.78 millionTim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade09/05/2024$2.95$3.10+5.08%$3.20$2.91281,727 shs$218.35 million09/04/2024$2.97$2.95-0.67%$3.15$2.94155,963 shs$214.14 million09/03/2024$3.16$2.97-6.01%$3.19$2.96117,189 shs$215.59 million09/02/2024$3.16$3.16$3.17$2.91289,400 shs$229.38 million08/30/2024$2.91$3.16+8.59%$3.17$2.91289,419 shs$229.38 million08/29/2024$2.95$2.91-1.36%$3.00$2.83110,076 shs$211.24 million08/28/2024$2.91$2.95+1.37%$2.97$2.88188,829 shs$207.78 million08/27/2024$2.98$2.91-2.35%$3.00$2.8655,888 shs$204.97 million08/26/2024$2.99$2.98-0.33%$3.08$2.9288,582 shs$209.90 million08/23/2024$2.76$2.99+8.33%$3.00$2.75179,545 shs$210.60 million08/22/2024$2.81$2.76-1.78%$2.89$2.7453,299 shs$194.40 million08/21/2024$2.85$2.81-1.40%$2.87$2.6884,389 shs$203.98 million08/20/2024$2.97$2.85-4.04%$2.94$2.7472,147 shs$200.74 million08/19/2024$2.77$2.97+7.22%$3.05$2.84144,699 shs$209.19 million08/16/2024$2.75$2.77+0.73%$2.80$2.6775,730 shs$195.11 million08/15/2024$2.61$2.75+5.36%$2.82$2.6295,341 shs$193.70 million08/14/2024$2.70$2.61-3.33%$2.75$2.58200,811 shs$183.84 million08/13/2024$2.73$2.70-1.10%$2.88$2.6644,493 shs$190.17 million08/12/2024$2.86$2.73-4.55%$2.91$2.7066,279 shs$192.27 million08/09/2024$2.80$2.86+2.14%$3.05$2.8271,789 shs$201.43 million08/08/2024$2.59$2.80+8.11%$2.83$2.58133,420 shs$197.22 million08/07/2024$2.61$2.59-0.77%$2.70$2.50126,096 shs$182.41 million08/06/2024$2.61$2.61$2.82$2.52132,776 shs$183.82 million08/05/2024$2.88$2.61-9.22%$2.74$2.57209,334 shs$183.82 million08/02/2024$3.10$2.88-7.10%$3.06$2.75210,539 shs$202.84 million08/01/2024$3.18$3.10-2.52%$3.18$2.96210,775 shs$218.33 million07/31/2024$3.18$3.18$3.30$3.11161,968 shs$223.97 million07/30/2024$3.15$3.18+0.95%$3.27$3.07105,906 shs$223.98 million Related Companies VNDA Stock Price Chart VYNE Stock Price Chart CARA Stock Price Chart PLRX Stock Price Chart TYRA Stock Price Chart ANAB Stock Price Chart SANA Stock Price Chart CRON Stock Price Chart DNTH Stock Price Chart ANNX Stock Price Chart Receive TRVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRVI) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.